Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
DNA Blocks the Lethal Effect of Human Beta-Defensin 2 Against Neisseria meningitidis
Stockholm University, Faculty of Science, Department of Molecular Biosciences, The Wenner-Gren Institute.
Stockholm University, Faculty of Science, Department of Molecular Biosciences, The Wenner-Gren Institute.
Stockholm University, Faculty of Science, Department of Molecular Biosciences, The Wenner-Gren Institute.
Stockholm University, Faculty of Science, Department of Molecular Biosciences, The Wenner-Gren Institute.
Show others and affiliations
Number of Authors: 92021 (English)In: Frontiers in Microbiology, E-ISSN 1664-302X, Vol. 12, article id 697232Article in journal (Refereed) Published
Abstract [en]

Neisseria meningitidis is a gram-negative bacterium that often asymptomatically colonizes the human nasopharyngeal tract. These bacteria cross the epithelial barrier can cause life-threatening sepsis and/or meningitis. Antimicrobial peptides are one of the first lines of defense against invading bacterial pathogens. Human beta-defensin 2 (hBD2) is an antimicrobial peptide with broad antibacterial activity, although its mechanism of action is poorly understood. Here, we investigated the effect of hBD2 on N. meningitidis. We showed that hBD2 binds to and kills actively growing meningococcal cells. The lethal effect was evident after 2 h incubation with the peptide, which suggests a slow killing mechanism. Further, the membrane integrity was not changed during hBD2 treatment. Incubation with lethal doses of hBD2 decreased the presence of diplococci; the number and size of bacterial microcolonies/aggregates remained constant, indicating that planktonic bacteria may be more susceptible to the peptide. Meningococcal DNA bound hBD2 in mobility shift assays and inhibited the lethal effect of hBD2 in a dose-dependent manner both in suspension and biofilms, supporting the interaction between hBD2 and DNA. Taken together, the ability of meningococcal DNA to bind hBD2 opens the possibility that extracellular DNA due to bacterial lysis may be a means of N. meningitidis to evade immune defenses.

Place, publisher, year, edition, pages
2021. Vol. 12, article id 697232
Keywords [en]
Neisseria meningitidis, infection, hBD2, aggregation, eDNA
National Category
Biological Sciences
Identifiers
URN: urn:nbn:se:su:diva-196515DOI: 10.3389/fmicb.2021.697232ISI: 000673298600001PubMedID: 34276631OAI: oai:DiVA.org:su-196515DiVA, id: diva2:1593919
Available from: 2021-09-14 Created: 2021-09-14 Last updated: 2025-06-26Bibliographically approved
In thesis
1. Neisseria meningitidis colonization and inhibitory factors from host cells and lactobacilli
Open this publication in new window or tab >>Neisseria meningitidis colonization and inhibitory factors from host cells and lactobacilli
2025 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Neisseria meningitidis (meningococcus) is a human-restricted bacterium that colonizes the nasopharyngeal epithelium, often asymptomatically. However, occasionally, meningococci can breach the epithelial barrier, enter the bloodstream, and cause invasive meningococcal disease. Following transmission via respiratory droplets, N. meningitidis must overcome epithelial defenses and compete with the resident commensal microbiota to establish colonization. This thesis focuses on the interplay between N. meningitidis, commensal Lactobacillus spp., and epithelial host defenses during the early stages of meningococcal colonization.

A key virulence factor of N. meningitidis is the type IV pilus, which facilitates bacterial adhesion to epithelial cells and the formation of multicellular structures known as microcolonies. These microcolonies provide protection to the bacteria against host responses. By contrast, commensal bacteria such as Lactobacillus spp. can interfere with meningococcal colonization by a multitude of antipathogenic mechanisms, including co-aggregation. Additionally, host epithelial cells contribute to defense by releasing antimicrobial peptides.

Paper I showed that the formation of meningococcal microcolonies is density-dependent and responsive to temperature changes. Moreover, lactate-induced dispersal from microcolonies required both functional protein synthesis and the ability to retract pili. Paper II built on these findings by showing that the antimicrobial peptide human beta-defensin 2 (hBD2) preferentially killed single cells of N. meningitidis over those in aggregates. This bactericidal effect was both time- and dose-dependent. Interestingly, extracellular DNA could bind to hBD2, reducing its effectiveness and offering a protective mechanism for N. meningitidis. Paper III explored a host-mediated defence mechanism involving Lactobacillus crispatus, which promoted the internalization of N. meningitidis into epithelial cells. This internalization hindered bacterial transcytosis and increased the acidic vacuoles, ultimately leading to intracellular killing of the pathogen. Thus, L. crispatus supports the host in clearing the infection. Paper IV further examined the interaction between L. crispatus and N. meningitidis, identifying a co-aggregative phenotype in which L. crispatus binds to meningococcal pili. This interaction impedes proper microcolony formation, rendering the pathogen more susceptible to antimicrobial agents.

Place, publisher, year, edition, pages
Stockholm: Institutionen för molekylär biovetenskap, Wenner-Grens institut, Department of Molecular Biosciences, The Wenner-Gren Institute, 2025. p. 68
Keywords
Neisseria meningitidis, Lactobacilli, host colonization, antimicrobial peptides, bacterial aggregation, host internalization
National Category
Microbiology
Research subject
Molecular Bioscience
Identifiers
urn:nbn:se:su:diva-244209 (URN)978-91-8107-306-5 (ISBN)978-91-8107-307-2 (ISBN)
Public defence
2025-09-05, P216, NPQ-huset, Svante Arrhenius väg 20, Stockholm, 13:00 (English)
Opponent
Supervisors
Available from: 2025-08-13 Created: 2025-06-12 Last updated: 2025-08-07Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Wassing, Gabriela M.Lidberg, KennySigurlásdóttir, SaraFrey, JonasSchroeder, KristenIlehag, NathalieLindås, Ann-ChristinJonas, KristinaJonsson, Ann-Beth

Search in DiVA

By author/editor
Wassing, Gabriela M.Lidberg, KennySigurlásdóttir, SaraFrey, JonasSchroeder, KristenIlehag, NathalieLindås, Ann-ChristinJonas, KristinaJonsson, Ann-Beth
By organisation
Department of Molecular Biosciences, The Wenner-Gren InstituteScience for Life Laboratory (SciLifeLab)
In the same journal
Frontiers in Microbiology
Biological Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 113 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf